Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/1995
03/21/1995US5399561 Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-oxochromanyl, 2-oxothiochromanyl or 2-oxo-1,2,3,4-tetrahydro-quinolinyl group having retinoid-like biological activity
03/21/1995US5399560 1,2,4-triazine products resulting from the inhibition of advanced glycosylation
03/21/1995US5399556 Complex of ranitidine and a zinc citrate; gastrointestinal disorders, peptic ulcers
03/21/1995US5399555 Viricides against retroviruses, especially HIV
03/21/1995US5399554 Viricides
03/21/1995US5399362 Once-a-day metoprolol oral dosage form
03/21/1995US5399360 Pharmaceutical compositions
03/21/1995US5399359 Controlled release oxybutynin formulations
03/21/1995US5399358 Sustained release formulations for 24 hour release of metroprolol
03/21/1995US5399356 Process for making solid dose forms containing bismuth
03/21/1995US5399355 Uniform penetration through skin
03/21/1995US5399348 Extract from Ginkgo biloba leaves, its method of preparation and pharmaceuticals containing the extract
03/21/1995US5399318 Blood sampling apparatus containing an anticoagulant composition
03/21/1995CA2037057C Photostabilizing method for ophthalmic solutions and the resulting opthalmic solutions therefrom
03/21/1995CA1334850C Ureylene-2,4,6-pyrimidine-3-oxide derivatives, their preparation and use in cosmetics and dermopharmacy
03/21/1995CA1334847C Oxadiazolopyrimidones, their preparation and application in cosmetics and dermopharmacy
03/21/1995CA1334846C Lipid derivatives of antiviral nucleosides, liposomal incorporation and method of use
03/21/1995CA1334828C Process for the preparation of a powdered extract of valerian roots
03/21/1995CA1334827C (s)-emopamil for the treatment of migraine
03/21/1995CA1334826C Pharmaceutical compositions comprising benzylidene-and cinnamylidene-malononitrile derivatives for the inhibition of proliferative processes in mammalian cells, certain such novelcompounds and their preparation
03/18/1995CA2131134A1 Process for preparing imidazopyridine derivatives
03/17/1995CA2131681A1 Antitumor agent
03/17/1995CA2130519A1 Antimigraine cyclobutenedione derivatives of tryptamines
03/17/1995CA2130078A1 Antimigraine cyclobutenedione derivatives of indolylalkyl-pyridinyl and pyrimidinylpiperazines
03/17/1995CA2112872A1 Preparation process of imidazole sulfur derivatives and new intermediate products obtained
03/16/1995WO1995007364A1 Nucleic acid ligands and improved methods for producing the same
03/16/1995WO1995007354A1 Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains
03/16/1995WO1995007302A1 Ganglioside gm3 derivative having fluorinated ceramide moiety
03/16/1995WO1995007294A1 Pseudo- and non-peptide bradykinin receptor antagonists
03/16/1995WO1995007291A1 Kininogen inhibitors
03/16/1995WO1995007284A1 Phosphinic acid derivatives with anti-hyper glycemic and/or anti-obesity activity
03/16/1995WO1995007282A1 Depression remedy
03/16/1995WO1995007281A1 A process for the preparation of 9-(2-hydroxy)-ethoxymethyl-guanine
03/16/1995WO1995007279A2 Process for the preparation of indolizine derivatives
03/16/1995WO1995007276A1 Bicyclic heterocyclic sulfonamide and sulfonic ester derivatives
03/16/1995WO1995007274A1 Bicyclic aromatic compounds as therapeutic agents
03/16/1995WO1995007271A1 Substituted oxazine and thiazine oxazolidinone antimicrobials
03/16/1995WO1995007270A1 Chelants as contrast enhancing agents
03/16/1995WO1995007262A1 Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands
03/16/1995WO1995007261A1 Polyamidic acid derivatives with antigastrin activity, a method for their preparation, and their pharmaceutical use
03/16/1995WO1995007258A1 Cyclohexanediurea derivative and process for producing the same
03/16/1995WO1995007257A1 Difluoro statone antiviral analogs
03/16/1995WO1995007103A1 Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
03/16/1995WO1995007097A1 Inhibition of heparin-binding
03/16/1995WO1995007091A1 Uses of vegetable oils
03/16/1995WO1995007089A1 Immunomodulating compositions from bile
03/16/1995WO1995007087A1 Sulfamethoxazole-specific immunosuppressive agents
03/16/1995WO1995007086A1 Nucleosides with anti-hepatitis b virus activity
03/16/1995WO1995007085A1 Surface active viscoelastic solutions for ocular use
03/16/1995WO1995007084A1 Blocking the accumulation of germs on human cells
03/16/1995WO1995007083A1 Ifosfamide lyophilisate composition
03/16/1995WO1995007082A1 A combination tablet comprising acetylsalicylic acid and a process for the preparation thereof
03/16/1995WO1995007081A1 Preparation for substitution therapy, containing at least one progestogen and at least one extrogen
03/16/1995WO1995007080A1 A method of treating liver disease and like indications with vasodilating agents
03/16/1995WO1995007079A1 Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine
03/16/1995WO1995007078A1 Epibatidine and derivatives thereof as cholinergic receptor agonists and antagonists
03/16/1995WO1995007077A1 Photochemotherapeutic compositions containing 5-aminolevulinic acid
03/16/1995WO1995007076A1 Inclusion complexes of racemic ibuproxam and of optically active ibuproxam with cyclodextrin derivatives, process for the preparation thereof, pharmaceutical preparations containing these inclusion complexes or containing optically active s-(+)-ibuproxam, and use thereof
03/16/1995WO1995007075A1 Novel aromatic amine derivatives
03/16/1995WO1995007073A1 Chemically-defined non-polymeric valency platform molecules and conjugates thereof
03/16/1995WO1995007071A1 Multi-phase compositions for an initial and delayed release of a medicament
03/16/1995WO1995007023A1 Method and composition for the treatment of apathy-amotivation syndrome
03/16/1995WO1995004528A3 PHARMACEUTICAL COMPOSITION CONTAINING A DRUG/β-CYCLODEXTRIN COMPLEX IN COMBINATION WITH AN ACID-BASE COUPLE
03/16/1995WO1995003809A3 Use of glucokinase inhibitors for the manufacture of a medicament for treating tumours
03/16/1995WO1995003786A3 New pharmaceutical compositions for topical use containing hyaluronic acid and its derivatives
03/16/1995WO1995003328A3 Melanoma-inhibiting protein
03/16/1995WO1995003050A3 Improved nicotine lozenge and therapeutic method for smoking cessation
03/16/1995WO1995002420A3 Prodrugs of protein tyrosine kinase inhibitors
03/16/1995WO1995002051A3 A pharmaceutical composition comprising antisense-nucleic acid for prevention and/or treatment of neuronal injury, degeneration and cell death and for the treatment of neoplasms
03/16/1995DE4432549A1 Pharmaceutical products with antithrombotic activity and process for the production thereof
03/16/1995DE4331168A1 Combination of N-acetyl-p-aminophenol with sulphur-containing carboxylic acids such as alpha-lipoic acid and derivatives thereof for controlling states of pain
03/16/1995DE4331147A1 Aqueous solution which can be administered intravenously
03/16/1995CA2171440A1 Epibatidine and derivatives thereof as cholinergic receptor agonists and antagonists
03/16/1995CA2171308A1 Process for the preparation of indolizine derivatives
03/16/1995CA2171295A1 Cyclohexanediurea derivative and process for producing the same
03/16/1995CA2171283A1 A process for the preparation of 9-(2-hydroxy)-ethoxymethyl-guanine
03/16/1995CA2171198A1 Method and composition for the treatment of apathy-amotivation syndrome
03/16/1995CA2171197A1 Blocking the accumulation of germs on human cells
03/16/1995CA2171115A1 Sulfamethoxazole-specific immunosuppressive agents
03/16/1995CA2170896A1 Kininogen inhibitors
03/16/1995CA2170648A1 Polyamidic acid derivatives with antigastrin activity, a method for their preparation, and their pharmaceutical use
03/16/1995CA2170488A1 Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
03/16/1995CA2170056A1 1,4-benzodioxane derivatives for treating cns disorders
03/16/1995CA2169633A1 Inhibition of heparin-binding
03/16/1995CA2169536A1 Nucleic acid ligands and improved methods for producing the same
03/16/1995CA2168738A1 Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands
03/16/1995CA2148502A1 Antidepressants
03/15/1995EP0643071A1 Compound for inhibiting bone resorption and accelerating osteogenesis
03/15/1995EP0643069A1 2'-deoxy-2'-fluorocoformycin and stereoisomers thereof
03/15/1995EP0643068A1 Erythromycin derivative
03/15/1995EP0643061A1 Novel cephalosporin antibiotics and processes for preparation thereof
03/15/1995EP0643060A2 Sulfonylbenzyl-substituted benzimidazoles, process for their preparation, and their pharmaceutical use
03/15/1995EP0643058A1 Crystals of an antimicrobial compound
03/15/1995EP0643057A1 Inhibitors of microsomal triglyceride transfer protein
03/15/1995EP0643053A1 Process for the manufacture of phenoxyphenoxyalkyl derivatives
03/15/1995EP0643044A1 Bis-biguanide compound useful as a disinfectant
03/15/1995EP0642799A1 Improved prodrugs for enzyme mediated activation
03/15/1995EP0642797A1 Formulation comprising antibacterial substance and antiulcer substance
03/15/1995EP0642793A1 Apoptosis inducer
03/15/1995EP0642792A1 Stabilized solutions of platinum (II) antitumor agents
1 ... 7034 7035 7036 7037 7038 7039 7040 7041 7042 7043 7044 7045 7046 7047 7048 7049 7050 7051 7052 7053 7054 ... 7860